Objective. To compare survival of patients with connective tissue disease-associated
interstitial lung disease (CTD-ILD) versus idiopathic pulmonary fibrosis (IPF) and patients …

Objective. Clinically meaningful change in systemic sclerosis (SSc) related interstitial lung
(SSc-ILD) disease is unknown. The aim of this study was to quantify change in pulmonary …

Background Interstitial lung disease (ILD) is a frequent complication of systemic sclerosis
(SSc) and a major cause of SSc-related deaths. This study aimed to determine the influence …

Objectives To identify overall disease course, progression patterns and risk factors
predictive for progressive interstitial lung disease (ILD) in patients with systemic sclerosis …

Rationale: Interstitial lung disease (ILD) represents a major challenge in systemic sclerosis
(SSc), but there are no precise, population-based data on its overall impact, limiting …

Objectives To explore prognostic and predictive markers of SSc-associated interstitial lung
disease (SSc-ILD) outcomes in a phase 3 trial (focuSSced) and prognostic markers in a real …

Objectives The aim of this study was to identify risk factors of percent predicted forced vital
capacity (ppFVC) decline in patients with SSc-associated interstitial lung disease (SSc-ILD) …

Systemic sclerosis (SSc) is a systemic autoimmune disease affecting multiple organ
systems, including the lungs. Interstitial lung disease (ILD) is the leading cause of death in …

Background: Interstitial lung disease (ILD) is one of the leading causes of mortality in
patients with systemic sclerosis (SSc). To further understand this patient population, we …

Objectives. In a multi-centre study, we sought to determine whether extent of disease on
high-resolution CT (HRCT) lung, reported using a simple grading system, is predictive of …